Braidwell LP Bio N Tech Se Transaction History
Braidwell LP
- $1.79 Billion
- Q4 2024
A detailed history of Braidwell LP transactions in Bio N Tech Se stock. As of the latest transaction made, Braidwell LP holds 309,865 shares of BNTX stock, worth $30.7 Million. This represents 1.98% of its overall portfolio holdings.
Number of Shares
309,865
Previous 247,750
25.07%
Holding current value
$30.7 Million
Previous $29.4 Billion
99.88%
% of portfolio
1.98%
Previous 0.83%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
364Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$814 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$436 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$425 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$188 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$179 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...